Cargando…

Volume substitution therapy with HES 130/0.4 (Voluven(®)) versus HES 450/0.7 (hetastarch) during major orthopedic surgery

Detalles Bibliográficos
Autores principales:	Gandhi, S, Warltier, D, Weiskopf, R, Bepperling, F, Baus, D, Jungheinrich, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098356/ http://dx.doi.org/10.1186/cc3269

Ejemplares similares

Comparison of 6% HES 130/0.4 in a balanced electrolyte solution versus 6% HES 130/0.4 in saline solution in cardiac surgery
por: Base, E, et al.
Publicado: (2006)

HES 130/0.4, a new HES specification: tissue storage after multiple infusions in rats
por: Bepperling, F, et al.
Publicado: (1999)

HES 130/0.4, a new HES specification: pharmacokinetics after multiple infusions of 10% solutions in healthy volunteers
por: Bepperling, F, et al.
Publicado: (1999)

Efficacy and safety of 10% HES 130/0.4 versus 10% HES 200/0.5 for plasma volume expansion in cardiac surgery patients
por: Ertmer, C, et al.
Publicado: (2011)

Does volume substitution with HES 130/0.4 affect renal safety in abdominal aortic surgery?
por: Godet, G, et al.
Publicado: (2006)

Advantages of 6% hydroxyethyl starch 130/0.4 (Voluven(®)) at repetitive high dose levels in patients with severe cranio-cerebral trauma
por: Neff, ThA, et al.
Publicado: (2001)

HES 130/0.4 impairs haemostasis and stimulates pro-inflammatory blood platelet function
por: Sossdorf, Maik, et al.
Publicado: (2009)

In vivo effect of hydroxyethyl starch solution (HES 130/0.4) on different fibrinogen assays
por: Schött, U, et al.
Publicado: (2014)

Balanced Hydroxyethylstarch (HES 130/0.4) Impairs Kidney Function In-Vivo without Inflammation
por: Schick, Martin Alexander, et al.
Publicado: (2015)

Large-dose hydroxyethyl starch (HES) 130/0.4 in elective coronary artery bypass surgery
por: Kasper, SM, et al.
Publicado: (2002)

Evaluation of effectiveness and safety of hydroxyethyl starch (HES 130 kDa/0.4) in burn resuscitation
por: Mokline, A, et al.
Publicado: (2012)

Hydroxyethyl starch HES 130/0.4 in paediatric surgery: results of an explorative, controlled, multicentre safety study
por: Lochbühler, H, et al.
Publicado: (2003)

Prospective observational study for perioperative volume replacement with 6% HES 130/0,42, 4% gelatin and 6% HES 200/0,5 in cardiac surgery
por: Winterhalter, M, et al.
Publicado: (2010)

Comparison of hydroxyethylstarch (HES 130/0.4) and 5% human albumin for volume substitution in pediatric neurosurgery: A retrospective, single center study
por: Schick, Martin A., et al.
Publicado: (2021)

Adverse effects of hydroxyethyl starch (HES 130/0.4) on intestinal barrier integrity and metabolic function are abrogated by supplementation with Albumin
por: Wong, Yuk Lung, et al.
Publicado: (2016)

The effect of HES130/0.4 sodium chloride solution on kidney function following early fluid resuscitation in shock patients
por: Jiang, Haiyan, et al.
Publicado: (2021)

Pharmacokinetics and tolerability of intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%) in 19 subjects with mild to severe renal impairment: terminal half life and peak concentration (C(max))remain unaffected
por: Jungheinrich, C, et al.
Publicado: (2001)

Concerns about renal safety of HES 130
por: Wiedermann, Christian J, et al.
Publicado: (2013)

Effect of intraoperative HES 6% 130/0.4 on the need for blood transfusion after major oncologic surgery: a propensity-matched analysis
por: Zampieri, Fernando Godinho, et al.
Publicado: (2013)

6% Hydroxyethyl starch (HES 130/0.4) diminishes glycocalyx degradation and decreases vascular permeability during systemic and pulmonary inflammation in mice
por: Margraf, Andreas, et al.
Publicado: (2018)

Assessment of Hydroxyethyl Starch (6% HES 130/0.4) Kidney Storage in Critically Ill Dogs: A Post-mortem Prospective Study
por: Adamik, Katja-Nicole, et al.
Publicado: (2022)

Effect of 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride (Voluven®) on complications after subarachnoid hemorrhage: a retrospective analysis
por: Khan, Shariq A, et al.
Publicado: (2013)

The Evaluation of Hydroxyethyl Starch (6% HES 130/0.4) Solution’s Potential Preventive Effects on Coagulation Status in Women with Gynecologic Malignancies Using Rotation Thromboelastography
por: Akay, Meltem Olga, et al.
Publicado: (2014)

Hydroxyethyl Starch (HES 130/0.4) Impairs Intestinal Barrier Integrity and Metabolic Function: Findings from a Mouse Model of the Isolated Perfused Small Intestine
por: Wong, Yuk Lung, et al.
Publicado: (2015)

Haemodynamic effects of a fluid challenge with hydroxylethyl starch 130/0.4 (Voluven(®)) in patients suffering from symptomatic vasospasm after subarachnoid haemorrhage
por: Van Tulder, L, et al.
Publicado: (2008)

Changes in the degree of substitution of HES in vivo and their influence on methods for determining HES concentrations in plasma
por: Lukasewitz, Peter, et al.
Publicado: (2023)

Survival time in severe hemorrhagic shock after perioperative hemodilution is longer with PEG-conjugated human serum albumin than with HES 130/0.4: a microvascular perspective
por: Martini, Judith, et al.
Publicado: (2008)

Correction: Hydroxyethyl Starch (HES 130/0.4) Impairs Intestinal Barrier Integrity and Metabolic Function: Findings from a Mouse Model of the Isolated Perfused Small Intestine
Publicado: (2015)

He’s Come!!
por: Stewart, A. T.
Publicado: (1869)

Efficacy and safety of 6% hydroxyethyl starch 130/0.4 (Voluven) for perioperative volume replacement in children undergoing cardiac surgery: a propensity-matched analysis
por: Van der Linden, Philippe, et al.
Publicado: (2015)

Sumoylation of Hes6 Regulates Protein Degradation and Hes1-Mediated Transcription
por: Lee, Jiwon, et al.
Publicado: (2015)

Comparing the Effects of 5% Albumin and 6% Hydroxyethyl Starch 130/0.4 (Voluven) on Renal Function as Priming Solutions for Cardiopulmonary Bypass: A Randomized Double Blind Clinical Trial
por: Hosseinzadeh Maleki, Mahmood, et al.
Publicado: (2016)

Is hydroxyethyl starch 130/0.4 safe?
por: Haase, Nicolai, et al.
Publicado: (2012)

Hyperhomocysteinemia induces injury in olfactory bulb neurons by downregulating Hes1 and Hes5 expression
por: Zhang, Jing-wen, et al.
Publicado: (2018)

‘When he’s up there he’s just happy and content’: Parents’ perceptions of therapeutic horseback riding
por: Boyd, Lauren, et al.
Publicado: (2017)

Hey2 functions in parallel with Hes1 and Hes5 for mammalian auditory sensory organ development
por: Li, Shuangding, et al.
Publicado: (2008)

HES6-1 and HES6-2 Function through Different Mechanisms during Neuronal Differentiation
por: Vilas-Boas, Filipe, et al.
Publicado: (2010)

Evolution of hes gene family in vertebrates: the hes5 cluster genes have specifically increased in frogs
por: Kuretani, Aya, et al.
Publicado: (2021)

Hes-6, an inhibitor of Hes-1, is regulated by 17β-estradiol and promotes breast cancer cell proliferation
por: Hartman, Johan, et al.
Publicado: (2009)

Effects on general safety and coagulation after long-term, high-dose volume therapy with 6% hydroxyethyl starch 130/0.4 in patients with acute ischemic stroke. Results of a randomized, placebo-controlled, double-blind study
por: Grauer, MT, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_rbfht1gsq75t003cpnbb08m8of